1 year return (CAGR)
16.08%
AGF A/S Exchange (CO, DKK)
AGF-B.CO
0.88
+0.00 (+0.22%)
Communication ServicesEntertainment
Loading...
3 year return (CAGR)
14.97%
5 year return (CAGR)
8.03%
10 year return (CAGR)
13.09%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
498.42M
Price/Sales
1.31
Ent value
542.30M
Price/Book
1.74
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.91 |
| Daily high | 0.94 |
| Daily low | 0.91 |
| Daily Volume | 264K |
| All-time high | 47.50 |
| 1y analyst estimate | - |
| Beta | 0.02 |
| EPS (TTM) | -0.03 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| AGF-B.CO | S&P500 | |
| Current price drop from All-time high | -98.15% | -1.76% |
| Highest price drop | -99.62% | -56.47% |
| Date of highest drop | 22 Dec 2017 | 9 Mar 2009 |
| Avg drop from high | -94.69% | -10.67% |
| Avg time to new high | 226 days | 12 days |
| Max time to new high | 5817 days | 1805 days |
News
Lagardere has slipped in recent months, yet over the past three years the stock is still modestly ahead. This puts fresh attention on whether today's share price lines up with the earnings that suppor...
September 30, 2026
ACEA has rewarded patient shareholders over recent years, yet the share price has been softer lately, which naturally raises the question of whether the current valuation is still well supported by it...
September 30, 2026
About 50% of Concentrix’s revenue is coming from business it earned since introducing AI tools three years ago.
September 29, 2026
Bayer has delivered a sharp share price recovery over the past year, which puts fresh attention on a simple question about the stock: Are investors now paying a price that still lines up with what the...
September 29, 2026
AI, machine learning, cloud analytics and multi-omics are accelerating drug discovery, enabling targeted, personalized therapies while reducing development time, cost and risk.Dublin, Sept. 29, 2026 (...
September 29, 2026
Charenton-le-Pont, 29 September 2026 Availability of the half-year financial report The Board of Directors of Marie Brizard Wine & Spirits approved the financial statements for the first half of 2026 ...
September 29, 2026
SAN DIEGO, September 29, 2026--Vividion announces publication of first peer-reviewed clinical data from Phase 1 study of VVD-214, investigational oral inhibitor of WRN.
September 29, 2026
Bayer (XTRA:BAYN) said the U.S. FDA has accepted a supplemental New Drug Application for Lynkuet (elinzanetant) for review. The filing covers moderate to severe vasomotor symptoms in women receiving e...
September 29, 2026
Avex Inc. (TSE: 7860) ("Avex"), the publicly traded global entertainment conglomerate led by CEO Katsumi Kuroiwa, has increased its ownership of S10 Entertainment acquiring 85% of the company from Sil...
September 29, 2026
ACEA (BIT:ACE) has come onto investor radars after recent share price weakness, with the stock down over the past week, month, and past 3 months despite a positive 1 year total return. Short term mome...
September 29, 2026